ATE328606T1 - Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera - Google Patents

Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera

Info

Publication number
ATE328606T1
ATE328606T1 AT02703130T AT02703130T ATE328606T1 AT E328606 T1 ATE328606 T1 AT E328606T1 AT 02703130 T AT02703130 T AT 02703130T AT 02703130 T AT02703130 T AT 02703130T AT E328606 T1 ATE328606 T1 AT E328606T1
Authority
AT
Austria
Prior art keywords
ulceras
treatment
peptide derivatives
chronic skin
thrombin peptide
Prior art date
Application number
AT02703130T
Other languages
English (en)
Inventor
Darrell H Carney
Original Assignee
Orthologic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthologic Corp filed Critical Orthologic Corp
Application granted granted Critical
Publication of ATE328606T1 publication Critical patent/ATE328606T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT02703130T 2001-07-27 2002-01-16 Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera ATE328606T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30819801P 2001-07-27 2001-07-27

Publications (1)

Publication Number Publication Date
ATE328606T1 true ATE328606T1 (de) 2006-06-15

Family

ID=23192964

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02703130T ATE328606T1 (de) 2001-07-27 2002-01-16 Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera

Country Status (12)

Country Link
US (3) US7049294B2 (de)
EP (1) EP1414487B1 (de)
JP (1) JP4192093B2 (de)
CN (1) CN100509055C (de)
AT (1) ATE328606T1 (de)
AU (1) AU2002236768B2 (de)
CA (1) CA2455756C (de)
DE (1) DE60212143T2 (de)
DK (1) DK1414487T3 (de)
ES (1) ES2271216T3 (de)
HK (1) HK1065719A1 (de)
WO (1) WO2003013569A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1414487T3 (da) * 2001-07-27 2006-10-09 Orthologic Corp Anvendelse af thrombin-peptidderivater til behandling af kroniske hudsår
ATE362939T1 (de) * 2002-07-02 2007-06-15 Orthologic Corp Dimere von thrombinpeptidderivaten
AU2003256343B2 (en) * 2002-07-02 2006-12-21 Orthologic Corp. Thrombin peptide derivatives
CA2551525C (en) 2003-12-31 2013-02-19 David W. Hobson Pharmaceutical composition for thrombin peptide derivatives
EP1934262A1 (de) * 2005-09-16 2008-06-25 The Board Of Regents, The University Of Texas System Antikörper gegen komplementäre peptide von thrombin oder teilen davon
EP2155234A1 (de) * 2007-04-10 2010-02-24 The Board of Regents,The University of Texas System Kombinationstherapie gegen chronische hautgeschwüre
US20110105400A1 (en) * 2008-03-26 2011-05-05 Orthologic Corp. Methods for treating acute myocardial infarction
US8952129B2 (en) * 2008-03-26 2015-02-10 The Board Of Regents Of The University Of Texas System Method of treating degenerative diseases
US20110110920A1 (en) * 2008-03-26 2011-05-12 Orthologic Corp. Method of treating peripheral arterial disease
WO2009120304A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
GB0916576D0 (en) * 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
CN102781368A (zh) * 2010-02-24 2012-11-14 赛诺龙医疗公司 体形塑造设备
US8806615B2 (en) 2010-11-04 2014-08-12 Mcafee, Inc. System and method for protecting specified data combinations
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) * 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
WO1996040033A1 (en) 1995-06-07 1996-12-19 Clarion Pharmaceuticals Inc. Non-biological patch for hemostasis
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
DK1414487T3 (da) * 2001-07-27 2006-10-09 Orthologic Corp Anvendelse af thrombin-peptidderivater til behandling af kroniske hudsår

Also Published As

Publication number Publication date
DE60212143D1 (de) 2006-07-20
JP2004538320A (ja) 2004-12-24
WO2003013569A2 (en) 2003-02-20
US20090029923A1 (en) 2009-01-29
US20060241049A1 (en) 2006-10-26
EP1414487A2 (de) 2004-05-06
DE60212143T2 (de) 2007-04-12
AU2002236768B2 (en) 2006-06-08
CN1556711A (zh) 2004-12-22
US7378500B2 (en) 2008-05-27
DK1414487T3 (da) 2006-10-09
US7833982B2 (en) 2010-11-16
WO2003013569A3 (en) 2003-12-11
US20040209819A1 (en) 2004-10-21
JP4192093B2 (ja) 2008-12-03
CA2455756C (en) 2013-04-02
CN100509055C (zh) 2009-07-08
US7049294B2 (en) 2006-05-23
CA2455756A1 (en) 2003-02-20
EP1414487B1 (de) 2006-06-07
HK1065719A1 (en) 2005-03-24
ES2271216T3 (es) 2007-04-16

Similar Documents

Publication Publication Date Title
ATE328606T1 (de) Verwendung von thrombin-peptidderivaten zur behandlung von chronischen hautulcera
DE69921156D1 (de) Verwendung von 5ht-6 antagonisten zur behandlung adhd
ATE462427T1 (de) Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
DE502005005659D1 (de) Verkürzte wundheilungsprozesse mittels neuartiger faservliese
ATE364386T1 (de) (s,s)-reboxetine zur behandlung von chronischen erschöpfungssyndrom
DE60233655D1 (de) R und retinoid x rezeptorenmodulatoren
DK1545587T3 (da) Lactoferrinsammensætninger og fremgangsmåder til behandling af diabetiske sår
DE60101669D1 (de) Verwendung von botulinum-toxin zur behandlung von diabetes
DE60142590D1 (de) Verwendung von Botulinum Toxin zur Behandlung von post-operative Schmerzen
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
ATE438405T1 (de) Verwendung von peptidantagonisten des zonulin zur behandlung von diabetes
SE0003537D0 (sv) Hudvänligt lim
DK1397681T3 (da) Fremgangsmåde til identificering af midler til behandling af diabetes
ATE300295T1 (de) Verwendung von baclofen zur behandlung von alkoholismus
ATE402699T1 (de) Verwendung von substituierten pyrazolen zur behandlung von allergien
DE60221884D1 (de) Mediziniscer verband
DE69912743D1 (de) Behandlung von follikulären lymphomen unter verwendung von inhibitoren des lymphotoxin (lt)-aktivierungsweges
DE50308460D1 (de) Verwendung von ambroxol zur behandlung von chronischen schmerzen
DE59805246D1 (de) Tissue-faktor zur beeinflussung von gefässbildung
DE60128084D1 (de) Verwendung von inaktives cln2 proenzym zur behandlung von lincl
DK1115375T3 (da) Anvendelse af mindst ét 10-hydroxy-2-decensyrederivat i et præparat til at fremme hudafstödning
WO2004053107A3 (en) Methods for treating diabetes
ATE306278T1 (de) Behandlung von knochenleiden mit adrenomedullin
DE60143390D1 (de) Methode zur behandlung von herzinsuffizienz
DE60219495D1 (de) Verwendung von Interleukin-18 zur Behandlung von UV-assoziierten Hautkrankheiten

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1414487

Country of ref document: EP